Assuring quality in point-of-care testing.
CYNTHIA BOWMAN, MD
Hope, ME 04847
TIM HAMILL, MD
Department of Laboratory Medicine
University of California
San Francisco, San Francisco,
(1.) Sutherland R. Market Perspectives on the (in vitro) diagnostics industry. Med Tech Innovation Center. January 10, 2010. http://www.mtic.dk/files/ Pdf/Market_Perspectives_Diagnostics_Industry_Arhus_ 20JAN10_Redac.pdf. Accessed January 4, 2011.
(2.) Lewandrowski K, Gregory K, Macmillan D. Assuring quality in point-of-care testing-evolution of technologies, informatics, and program management. Arch Pathol Lab Med. 2011; 135(11):1405 1414.
(3.) College of American Pathologists Point of Care Testing Committee 2010-2011. Point of Care Testing Tool Kit. College of American Pathologists. http://www.cap.org/apps/cap.portaR_nfpb 5 true& cntvwrPtlt_actionOverride5%2Fportlets%2Fcontent Viewer%2Fshow&_windowLabel5cntvwrPtlt&cntvwr Ptlt%7BactionForm.contentReference%7D5committees %2Fpointofcare%2Fpoct_toolkit.html&_state5 maximized&_pageLabel5cntvwr. Accessed January 4, 2011.
Dr Bowman is the immediate past chair and Dr Hamill is the current vice chair of the College of American Pathologists Point of Care Testing Resource Committee. The authors have no relevant financial interest in the products or companies described in this article.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Letters to the Editor|
|Author:||Bowman, Cynthia; Hamill, Tim|
|Publication:||Archives of Pathology & Laboratory Medicine|
|Article Type:||Letter to the editor|
|Date:||May 1, 2012|
|Previous Article:||Advances in treatment of lung cancer with targeted therapy.|
|Next Article:||Is obstructive sleep apnea a cause of idiopathic pulmonary fibrosis?|